In today’s market, where affordability is stretched thin and borrower competition is fierce, lenders can’t afford to stop at “yes.” The real differentiator isn’t just qualifying a borrower for a loan ...

In 2025, fewer biotech deals are getting done, but the dollars behind them are bigger than ever. Having spent years working with emerging and fast-growth life sciences companies, I’ve seen firsthand ...